Try our Advanced Search for more refined results

In re: McKinsey & Co., Inc. National Prescription Opiate Consultant Litigation

Track this case

Case overview

Case Number:

3:21-md-02996

Court:

California Northern

Nature of Suit:

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Charles R. Breyer

Firms

Companies

Government Agencies

Sectors & Industries:

  1. April 04, 2024

    Tribes And McKinsey Take Final Step In $39.5M Opioid Deal

    A California judge signed off Thursday on the completion of a $39.5 million nationwide settlement deal that resolves all opioids litigation brought by federally recognized tribes against McKinsey & Co.

  2. February 02, 2024

    McKinsey's $78M Opioid Deal With Health Plans Hits Snag

    A California federal judge considering a $78 million deal between third-party payors and McKinsey & Co. in multidistrict litigation over the consulting firm's marketing advice to opioid makers held off on preliminarily approving the deal Friday, instead setting a new hearing date after some plaintiffs' attorneys raised issues with aspects of the deal.

  3. September 27, 2023

    McKinsey Strikes $230M Opioid Deal With Gov'ts And Schools

    Management consulting giant McKinsey & Co. has struck a deal to pay a total of $230 million to end claims brought by local governments and school districts that its work advising drugmakers contributed to the opioid crisis, according to documents filed late Tuesday in California federal court.

  4. July 20, 2023

    Last Claims Tossed In McKinsey Opioid Marketing MDL

    A California federal judge on Thursday dismissed the remaining allegations from the caretakers of infants born with neonatal abstinence syndrome caused by their mother's use of opioids before or during pregnancy in multidistrict litigation against McKinsey & Co. Inc., finding the complaint doesn't establish a duty to the parents, or adequately plead their reliance on any purported misrepresentations made by the management consulting firm.

  5. June 30, 2023

    Opioid Judge Mulls Liability Of 'Don Draper' McKinsey

    A California federal judge expressed doubts Friday about whether McKinsey & Co. should face negligence claims brought by babies born with neonatal abstinence syndrome caused by their mothers' opioid use, probing for evidence that McKinsey knew opioids were addictive when it gave marketing advice as "the Don Draper for the industry." 

  6. June 23, 2023

    McKinsey Nears Opioid MDL Deal With Tribes, Insurance Plans

    Tribes and health insurance plans are nearing a deal with McKinsey & Co. to settle claims the management consultant worked with pharmaceutical companies to push addictive opioids, according to a joint status report filed on Friday.

  7. April 27, 2023

    McKinsey, Plaintiffs Spar Over Picking Opioid Bellwether Tribe

    Plaintiffs suing McKinsey & Co. for allegedly masterminding schemes to help Purdue Pharma LP and the Sackler family sell addictive opioids have urged a California federal judge to select a Washington state tribe as the first tribal bellwether case, but McKinsey said it wants a more in-depth selection process.

  8. March 06, 2023

    Tribes And Others Fight To Keep McKinsey Opioid Suit Alive

    Tribes, health insurance plans and children born with neonatal abstinence syndrome suing McKinsey & Co. for masterminding schemes to help Purdue Pharma LP and the Sackler family sell addictive opioids have urged a California federal judge to reject the management consultant's attempt to throw out their multidistrict litigation.

  9. January 26, 2023

    Ariz. Tribe Sues McKinsey Over Opioid Crisis

    The White Mountain Apache Tribe on Wednesday hit McKinsey & Co. with a RICO suit over the firm's alleged role in the tribe's opioid epidemic in San Francisco federal court, claiming it aided opioid makers in executing a marketing strategy to boost sales of the addictive painkillers, joining a number of jurisdictions in the growing multidistrict litigation.

  10. November 02, 2022

    After Pharmacy Deals, New Opioid Sellers In Legal 'Bull's-Eye'

    Multibillion-dollar settlements with top pharmacy retailers will shift a historic barrage of opioid litigation away from the last of its early targets and toward groups of pharmaceutical sellers and advisers whose business practices and legal defenses have received little attention, according to plaintiffs counsel and court records.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!